Patent 7863420 was granted and assigned to Biotest AG on January, 2011 by the United States Patent and Trademark Office.
The invention relates to a method for separating fibronectin from plasma fractions by adjusting a pH value of less than 5.4 such that fibronectin is precipitated and extracted from the solution.